Musculoskeletal diseases including Osteoporosis and Osteoarthritis (OA) affect millions of people each year. Research and development in this therapeutic area continues to grow at a rapid pace evidenced by the emergence of new treatments being developed and tested in the clinic.
As the world's largest imaging core lab, BioClinica has the expertise and medical imaging solutions to successfully support clinical trials for musculoskeletal indications. Our medical affairs, technologists and operational teams have the experience and skills necessary to deliver quality service and independent image review in support of your trial.
BioClinica's musculoskeletal expertise is reflected in the form of support for the latest developments in imaging endpoints and for all available imaging modalities. Our staff ensures full 21 CFR Part 11 compliance and maintains contact with the FDA to implement regulatory guidance.
When you choose BioClinica, you can be sure you are getting the best in the following areas:
A dedicated team supporting Musculoskeletal trials.
Dedicated radiologists and a network of industry leaders.
Contributing to the FDA approval of novel drugs.
Clinical trial experience covering prevalent indications.
Application of the latest quantitative imaging endpoints.
Strong operational foundation ensuring timely results.